PMID- 1104348 OWN - NLM STAT- MEDLINE DCOM- 19760301 LR - 20191028 IS - 0093-6391 (Print) IS - 0093-6391 (Linking) VI - 2 IP - 6-7 DP - 1975 TI - Post-coital contraceptive and uterotrophic effects of luteinizing hormone releasing hormone. PG - 445-58 AB - LRH, administered subcutaneously (s.c.) or orally (p.o.) to female rats, was capable of interfering with pregnancy when given on various days of gestation. A 100% inhibition of pregnancy was demonstrated at daily s.c. doses of 1000 mug/rat administered over days 1-7; LRH also was effective as an interceptive, terminating pregnancy in 100% of rats when delivered from days 7-12 of pregnancy at a daily dose of 1000 mug/rat s.c. or p.o. An 80% inhibition also was observed in rabbits administered LRH from days 1-7 at a total dose of 1000 mug/kg, s.c. Uterotrophic studies demonstrated that LRH, administered s.c. to intact immature mice, produces a dose-related increase in uterine and ovarian weight and initiates vaginal opening. The hypothalamic hormone also produced a dose-related increase in uterine weight in ovariectomized mice and hypophysectomized rats. The data suggest that LRH has a post-coital contraceptive effect, presumably acting via hyperstimulation of the hypophysial-ovarian steroid-uterine axis, and/or by a direct extrapituitary (uterine) effect. FAU - Corbin, A AU - Corbin A FAU - Beattie, C W AU - Beattie CW LA - eng PT - Journal Article PL - United States TA - Endocr Res Commun JT - Endocrine research communications JID - 0426337 RN - 0 (Contraceptives, Postcoital) RN - 33515-09-2 (Gonadotropin-Releasing Hormone) SB - IM MH - Animals MH - Castration MH - Contraceptives, Postcoital/*pharmacology MH - Female MH - Gonadotropin-Releasing Hormone/*pharmacology MH - Hypophysectomy MH - Mice MH - Ovary/drug effects/*physiology MH - Pregnancy MH - Rabbits MH - Rats MH - Uterus/drug effects/*physiology OID - PIP: 752414 OID - POP: 00023847 OAB - A study demonstrated that luteinizing hormone-releasing hormone (LRH ) when administered subcutaneously (sc) or orally (po) to female rats can interfere with pregnancy and that the hormone posseses extrapituitary activity. Pregnancy was inhibited 100% when daily sc doses of 1000 mcg/rat were given from Days 1 to 7. LRH effectively intercepted and terminated pregnancy in 100% of rats delivered from Days 7 to 12 of pregnancy at a daily dose of 1000 mcg/rat sc or po. When rabbits were administered LRH from Days 1 to 6 at a total dose of 1000 mcg/kg sc, and 80% inhibition was noted. Uterotrophic studies revealed that LRH, when administered sc to intact immature mice, produced a dose-related increase in uterine and ovarian weight and initiates vaginal opening. A dose-related increase in uterine weight as produced by the hypothalamic hormone was exhibited in ovariectomized mice and hypophysectomized rats. Data demonstrate that LRH has an extrapituitary and antipregnancy postcoital effect. OABL- eng OTO - PIP OT - *Animals, Laboratory OT - Biology OT - Clinical Research OT - Contraception OT - Contraceptive Agents OT - Contraceptive Agents, Female OT - *Contraceptive Agents, Postcoital OT - Endocrine System OT - Family Planning OT - *Fertility Control, Postconception OT - Genitalia OT - Genitalia, Female OT - Gonadotropins OT - Gonadotropins, Pituitary OT - Hormones OT - *Luteinizing Hormone OT - *Ovarian Effects OT - Ovary OT - Physiology OT - *Pituitary Hormone Releasing Hormones OT - Research Methodology OT - Urogenital System OT - *Uterine Effects OT - Uterus EDAT- 1975/01/01 00:00 MHDA- 1975/01/01 00:01 CRDT- 1975/01/01 00:00 PHST- 1975/01/01 00:00 [pubmed] PHST- 1975/01/01 00:01 [medline] PHST- 1975/01/01 00:00 [entrez] AID - 10.1080/07435807509084166 [doi] PST - ppublish SO - Endocr Res Commun. 1975;2(6-7):445-58. doi: 10.1080/07435807509084166.